Related Experiment Video
Updated: Oct 16, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in
Ashish Sarraju1, Andrew Ward2, Sukyung Chung3
1Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Insights
Electronic health record (EHR)-based machine learning (ML) models significantly improve cardiovascular disease (CVD) risk stratification for secondary prevention. These ML models outperformed traditional risk scores in a multiethnic patient population.
Area of Science:
- Medical Informatics
- Cardiology
- Machine Learning
Background:
- Effective cardiovascular disease (CVD) prevention relies on accurate identification of high-risk patients.
- The utility of electronic health record (EHR)-based machine learning (ML) models for CVD risk stratification compared to traditional scores is not well-established.
Purpose of the Study:
- To compare the performance of EHR-based ML models against the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention (TRS 2°P) for CVD risk stratification.
- To evaluate the ability of ML models to predict 5-year CVD event risk in a real-world, multiethnic population.
Main Methods:
- A cohort of 32,192 patients from a large health system was identified, with 80% used for training and 20% for testing ML models.
- Various ML models (Random Forests, Gradient-Boosted Machines, XGBoost, Logistic Regression) were trained using EHR data to predict 5-year CVD event risk.
- Model performance was assessed using the area under the receiver operating characteristic curve (AUC) and compared with TRS 2°P.
Main Results:
- ML models demonstrated good performance, with XGBoost achieving an AUC of 0.70 in the full CVD cohort and 0.71 in the atherosclerotic CVD (ASCVD) cohort.
- The traditional TRS 2°P score performed poorly, with AUCs of 0.51 and 0.50 for CVD and ASCVD patients, respectively.
- ML models identified novel predictive variables, including education level and primary care visit frequency.
Conclusions:
- EHR-based ML models significantly enhance CVD risk stratification for secondary prevention in a real-world, multiethnic setting.
- ML approaches offer a superior alternative to traditional risk scores for identifying high-risk patients for CVD prevention strategies.
Objectives:
Identifying high-risk patients is crucial for effective cardiovascular disease (CVD) prevention. It is not known whether electronic health record (EHR)-based machine-learning (ML) models can improve CVD risk stratification compared with a secondary prevention risk score developed from randomised clinical trials (Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention, TRS 2°P).
Methods:
We identified patients with CVD in a large health system, including atherosclerotic CVD (ASCVD), split into 80% training and 20% test sets. A rich set of EHR patient features was extracted. ML models were trained to estimate 5-year CVD event risk (random forests (RF), gradient-boosted machines (GBM), extreme gradient-boosted models (XGBoost), logistic regression with an L2 penalty and L1 penalty (Lasso)). ML models and TRS 2°P were evaluated by the area under the receiver operating characteristic curve (AUC).
Results:
The cohort included 32 192 patients (median age 74 years, with 46% female, 63% non-Hispanic white and 12% Asian patients and 23 475 patients with ASCVD). There were 4010 events over 5 years of follow-up. ML models demonstrated good overall performance; XGBoost demonstrated AUC 0.70 (95% CI 0.68 to 0.71) in the full CVD cohort and AUC 0.71 (95% CI 0.69 to 0.73) in patients with ASCVD, with comparable performance by GBM, RF and Lasso. TRS 2°P performed poorly in all CVD (AUC 0.51, 95% CI 0.50 to 0.53) and ASCVD (AUC 0.50, 95% CI 0.48 to 0.52) patients. ML identified nontraditional predictive variables including education level and primary care visits.
Conclusions:
In a multiethnic real-world population, EHR-based ML approaches significantly improved CVD risk stratification for secondary prevention.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...